Merck

This is the first oral antiviral drug to be included in the WHO's treatment guidelines for COVID-19.

Now playing Next

WHO recommends Merck antiviral pill to treat high-risk COVID patients

TOP TAGS

EU POLICY UNITED KINGDOM EUROPEAN UNION ISRAEL HAMAS WAR UKRAINE WAR EUROPEAN PARLIAMENT TIKTOK ARTIFICIAL INTELLIGENCE

More about this topic

The COVID-19 treatment pill called molnupiravir, which is being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP.

Now playing Next

Could COVID pills be a game-changer for vaccine equity?

A new antiviral pill that has been shown to treat COVID-19 in high-risk patients is seeking authorisation.

20/10/2021

Pfizer and Merck team up to work on anti-cancer treatment

Now playing Next

Pfizer and Merck team up to work on anti-cancer treatment

17/11/2014